Chimeric antigen receptor T cells engineered to secrete CD40 agonist antibodies enhance antitumor efficacy

Overview of attention for article published in Journal of Translational Medicine, February 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 6,336 followers.

RT @CARTTherapy: Chimeric antigen receptor T cells engineered to secrete CD40 agonist antibodies enhance antitumor efficacy https://t.co/qr…

RT @CARTTherapy: Chimeric antigen receptor T cells engineered to secrete CD40 agonist antibodies enhance antitumor efficacy https://t.co/qr…

Chimeric antigen receptor T cells engineered to secrete CD40 agonist antibodies enhance antitumor efficacy https://t.co/qrKErQdsgT #CART #CARTcell #immunotherapy #tcellrx #CARTcells #CellTherapy

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.